TNON insider transaction filings
Tenon Medical, Inc. — 34 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-08-04. Screen TNON transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-04 | 4 | Ferrari Richard — Director | Option exercise (M): 64,479 @ $0 · Option exercise (M): 64,479 (derivative) @ $0 | EDGAR |
| 2026-08-04 | 4 | Hochschuler Stephen — Director | Option exercise (M): 10,732 @ $0 · Option exercise (M): 10,732 (derivative) @ $0 | EDGAR |
| 2026-08-04 | 4 | HOWARD IVAN — Director | Option exercise (M): 10,732 @ $0 · Option exercise (M): 10,732 (derivative) @ $0 | EDGAR |
| 2026-08-04 | 4 | Jacques Kristine M — Director | Option exercise (M): 10,147 @ $0 · Option exercise (M): 10,147 (derivative) @ $0 | EDGAR |
| 2026-08-04 | 4 | WEIGLE ROBERT K — Director | Option exercise (M): 10,732 @ $0 · Option exercise (M): 10,732 (derivative) @ $0 | EDGAR |
| 2026-08-04 | 4 | FOSTER STEVEN M — CEO and President, Director | Option exercise (M): 140,936 @ $0 · Tax withholding (F): 41,788 @ $0.20 · Option exercise (M): 140,936 (derivative) @ $0 | EDGAR |
| 2026-08-04 | 4 | GINN RICHARD — Chief Technology Officer, Director | Option exercise (M): 126,577 @ $0 · Tax withholding (F): 44,809 @ $0.20 · Option exercise (M): 126,577 (derivative) @ $0 | EDGAR |
| 2026-08-04 | 4 | Williamson Kevin — Chief Financial Officer | Option exercise (M): 58,987 @ $0 · Tax withholding (F): 12,978 @ $0.20 · Option exercise (M): 58,987 (derivative) @ $0 | EDGAR |
| 2026-05-05 | 4 | Geist Wyatt D. — Chief Innovation Officer | Grant/award (A): 136,401 @ $0 | EDGAR |
| 2026-05-05 | 4 | Grawey Nathaniel A. — Chief Commercial Officer | Grant/award (A): 68,201 @ $0 | EDGAR |
| 2026-03-05 | 4 | Williamson Kevin — Chief Financial Officer | Option exercise (M): 1,041 @ $0 · Option exercise (M): 1,041 (derivative) @ $0 | EDGAR |
| 2026-01-05 | 4 | WEIGLE ROBERT K — Director | Option exercise (M): 10,732 @ $0 · Tax withholding (F): 3,413 @ $0.93 · Option exercise (M): 10,732 (derivative) @ $0 | EDGAR |
| 2026-01-05 | 4 | FOSTER STEVEN M — CEO and President, Director | Option exercise (M): 140,936 @ $0 · Option exercise (M): 140,936 (derivative) @ $0 | EDGAR |
| 2026-01-05 | 4 | GINN RICHARD — Chief Technology Officer, Director | Option exercise (M): 126,577 @ $0 · Tax withholding (F): 47,426 @ $0.93 · Option exercise (M): 126,577 (derivative) @ $0 | EDGAR |
| 2026-01-05 | 4 | Jacques Kristine M — Director | Option exercise (M): 10,146 @ $0 · Option exercise (M): 583 @ $0 · Option exercise (M): 10,146 (derivative) @ $0 · Option exercise (M): 583 (derivative) @ $0 | EDGAR |
| 2026-01-05 | 4 | Williamson Kevin — Chief Financial Officer, Director | Option exercise (M): 58,987 @ $0 · Tax withholding (F): 18,518 @ $0.93 · Option exercise (M): 58,987 (derivative) @ $0 | EDGAR |
| 2026-01-05 | 4 | HOWARD IVAN — Director | Option exercise (M): 10,732 @ $0 · Tax withholding (F): 3,327 @ $0.93 · Option exercise (M): 10,732 (derivative) @ $0 | EDGAR |
| 2026-01-05 | 4 | Hochschuler Stephen — Director | Option exercise (M): 10,732 @ $0 · Tax withholding (F): 3,327 @ $0.93 · Option exercise (M): 10,732 (derivative) @ $0 | EDGAR |
| 2026-01-05 | 4 | Ferrari Richard — Director | Option exercise (M): 64,478 @ $0 · Option exercise (M): 64,479 (derivative) @ $0 | EDGAR |
| 2025-12-29 | 4 | WEIGLE ROBERT K — Director | Option exercise (M): 78 @ $0 · Option exercise (M): 78 @ $0 · Option exercise (M): 78 (derivative) @ $0 · Option exercise (M): 78 (derivative) @ $0 | EDGAR |
| 2025-12-29 | 4 | HOWARD IVAN — Director | Option exercise (M): 78 @ $0 · Option exercise (M): 78 @ $0 · Option exercise (M): 78 (derivative) @ $0 · Option exercise (M): 78 (derivative) @ $0 | EDGAR |
| 2025-12-22 | 4 | Jacques Kristine M — Director | Grant/award (A): 1,750 (derivative) @ $0 | EDGAR |
| 2025-12-19 | 4 | Williamson Kevin — Chief Financial Officer, Director | Option exercise (M): 2,083 @ $0 · Grant/award (A): 6,250 (derivative) @ $0 · Option exercise (M): 2,083 (derivative) @ $0 | EDGAR |
| 2025-11-18 | 4 | FOSTER STEVEN M — CEO and President, Director | Purchase (P): 19,455 · Purchase (P): 19,455 (derivative) | EDGAR |
| 2025-11-18 | 4 | Geist Wyatt D. — Chief Innovation Officer | Purchase (P): 19,455 · Purchase (P): 19,455 (derivative) | EDGAR |
| 2025-11-18 | 4 | Grawey Nathaniel A. — Chief Commercial Officer | Purchase (P): 101,167 · Purchase (P): 101,167 (derivative) | EDGAR |
| 2025-10-15 | 4 | FOSTER STEVEN M — CEO and President, Director | Grant/award (A): 281,872 (derivative) @ $0 | EDGAR |
| 2025-10-15 | 4 | WEIGLE ROBERT K — Director | Grant/award (A): 21,464 (derivative) @ $0 | EDGAR |
| 2025-10-15 | 4 | GINN RICHARD — Chief Technology Officer, Director | Grant/award (A): 253,153 (derivative) @ $0 | EDGAR |
| 2025-10-15 | 4 | Jacques Kristine M — Director | Grant/award (A): 20,293 (derivative) @ $0 | EDGAR |
| 2025-10-15 | 4 | Williamson Kevin — Chief Financial Officer, Director | Grant/award (A): 117,974 (derivative) @ $0 | EDGAR |
| 2025-10-15 | 4 | HOWARD IVAN — Director | Grant/award (A): 21,464 (derivative) @ $0 | EDGAR |
| 2025-10-15 | 4 | Hochschuler Stephen — Director | Grant/award (A): 21,464 (derivative) @ $0 | EDGAR |
| 2025-10-15 | 4 | Ferrari Richard — Director | Grant/award (A): 128,957 (derivative) @ $0 | EDGAR |
Recent 8-K events — Tenon Medical, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-13 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-10 | 8-K | 3.03 — Material Modification to Rights of Security Holders 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-24 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-07-20 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-10 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-07-02 | 8-K | 1.01 — Entry into a Material Definitive Agreement 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-12 | 8-K | 1.01 — Entry into a Material Definitive Agreement 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-11 | 8-K | 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-22 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | EDGAR |
| 2026-05-12 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=TNON returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →